具有选择性和显著的布基胆酶抑制的基甲基碳酸盐:计算研究和物理化学特性
Anamarija Raspudić1, Ilijana Odak1, Milena Mlakić2
1Department of Chemistry, Faculty of Science and Education, University of Mostar, Matice Hrvatske bb, 88 000 Mostar, Bosnia and Herzegovina.
Biomolecules
|June 26, 2025
概括
研究人员开发了新型的基甲基乙烯基酸盐作为选择性布基胆化酶 (BChE) 抑制剂,用于阿尔茨海默氏症等神经退行性疾病. 化合物16显示强大的BCHE抑制和抗炎作用,表明治疗潜力.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病,如阿尔茨海默病,是全球日益严重的健康问题.
- 乙基胆酶 (BChE) 是阿尔茨海默病治疗干预的关键标.
- 开发具有良好的药理动力学特征的选择性BChE抑制剂至关重要.
研究的目的:
- 为了合成和表征新型的基甲基乙烯基聚酸盐.
- 评估它们作为选择性丁胆酶 (BChE) 抑制剂的潜力.
- 探索它们在神经退行性疾病中的治疗应用.
主要方法:
- 从复星类似物中合成了19种新型的甲基甲基.
- 使用NMR,HRMS和X射线衍射进行结构确认.
- 在体外酶抑制试验 (BChE 和 AChE),抗炎试验,在中ADME (T) 分析,分子对接和分子动力学模拟.
主要成果:
- 所有合成的化合物都对BChE表现出对ACHE的选择性.
- 化合物16显示出强大的BCHE抑制 (IC50=26.5nM) 和中度的抗炎活性.
- 在 silico 研究表明,大多数化合物具有有利的药理动力学特性和低的突变性潜力.
- 分子模拟证实了BChE活性部位内的稳定结合.
结论:
- 基甲基基酸是针对BChE的一类有希望的化合物.
- 化合物16是开发用于阿尔茨海默病和相关神经退行性疾病的新疗法的潜在主要候选者.
- 需要对抗炎性质和体内疗效进行进一步的研究.
相关概念视频
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
668
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
668
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.3K
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.4K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.4K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:22Cholinesterases: Distribution and Function
573
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
573
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K